[1]
Fishbane, S., Wen, W. , Munera, C., Menzaghi, F. and McCafferty, K. 2021. Long-term Safety and Efficacy of Difelikefalin in Subjects With Chronic Kidney Disease–Associated Pruritus: Analysis From KALM-1 and KALM-2. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s75. DOI:https://doi.org/10.25251/skin.5.supp.75.